GUSELKUMAB (Tremfya®)

Clinical Indication

For previously treated moderately to severely active Crohn's disease

Comments

in line with NICE TA1095

Date of classification

November 2025

Red

Medicines which should be prescribed only in a specialist setting usually within a secondary or tertiary care service. NB: Some highly specialised RED medicines e.g. injectable treatments for cancer are not included on the LLR APC website list.